DUSP6 and glioblastoma: Further, this study reports only an in vitro characterization based on western blot analysis of the classical mesenchymal markers (Additional file 1) and, from the point-of-view of phenotypic characterization, the invasion assay does not exhaustively demonstrate that DUSP6 activates EMT in GBM by enhancing its invasive properties.